Jasmine M. Zain, M.D.
Dr. Zain first joined City of Hope in 2002 where she specialized in the treatment of patients with cutaneous T-cell lymphoma, allogeneic stem cell transplantation, and early phase clinical trials in hematologic malignancies. She left City of Hope to assume a leadership position as director of the bone marrow transplant program at New York University Langone Medical Center, before joining the faculty at Columbia University in 2012. She returned to City of Hope in 2014 to take a position as the Director of the T cell lymphoma program.
Triple-board certified in hematology, oncology and internal medicine, Dr. Zain is an active member of several professional associations and has published more than 78 peer-reviewed publications, abstracts and book chapters.
She has been invited to speak both nationally and internationally. Dr. Zain is a superb clinician, a productive and creative clinical researcher, and an outstanding and experienced teacher.
Duarte Cancer Center
Duarte, CA 91010
California medical license
New York medical license
Board Certification: American Board of Internal Medicine, American Board of Hematology, American Board of Oncology
M.D. 1987, M.D., Fatima Jinnah Medical College for Women, Lahore, Punjab, Pakistan
1994-1999, Fellow, Hematology/Oncology, New York University Medical Center, New York, New York
1990-1992, Residency, Internal Medicine, North Shore Hospital of Forest Hills, (Formerly La Guardia Hospital), Forest Hills, New York
1989-1990, Internship, Internal Medicine, North Shore Hospital of Forest Hills, Forest Hills, New York
2021-present, Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2014-present, Director, T Cell Lymphoma Program, City of Hope, Duarte, CA
2014-2021, Associate Clinical Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2012-2014, Associate Professor of Medicine, Associate Director of BMT, Columbia University, New York, NY
2009-2014, Director, Bone Marrow Transplant Program, Department of Medicine, NYU Langone Medical Center, New York, NY
2009-2012, Assistant Professor, Division of Hematology & Medical Oncology, NYU Langone Medical Center, New York, NY
2008-2009, Clinical Assistant Professor, Columbia University Medical Center, New York, NY
2002-2008, Staff Physician, City of Hope, Duarte, CA
2001-2002, Assistant Professor, Department of Medicine, University of Connecticut, Stamford, CT
1999-2001, Hematology/Oncology, Attending Physician, The Brooklyn Hospital Center, Brooklyn, NY
1992-1999, Teaching Assistant, New York University Medical Center, New York, NY
1992-1994, General Internist, Internal Medicine, Northern Hospital of Surry County, Mt. Airy, NC
1988-1989, House Officer, Internal Medicine/Department of Surgery, Sir Ganga Ram Hospital, Lahore, Pakistan
American Society of Hematology
American Society of Oncology
American Association of Cancer Research
American Society for Blood and Marrow Transplantation
International Society of Cutaneous Lymphoma
United States Cutaneous Lymphoma Consortium
- Huen A, Haverkos BM, Zain J, Radhakrishnan R, Lechowicz MJ, Devata S, Korman NJ, Pinter-Brown L, Oki Y, Barde PJ, Nair A, Routhu KV, Viswanadha S, Vakkalanka S, Iyer SP. Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma. Cancers (Basel) . 2020 Aug 15;12(8):2293
- Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H.
- NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1460-1467
- Zic, J.A., W. Ai, O.E. Akilov, J.B. Carter, M. Duvic, F. Foss, M. Girardi, A.A. Gru, E. Kim, A. Musiek, E.A. Olsen, S.M. Schieke, M. Shinohara, J.M. Zain, and L.J. Geskin, United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic. J Am Acad Dermatol, 2020.
- Mehta-Shah, N., S.M. Horwitz, S. Ansell, W.Z. Ai, J. Barnes, S.K. Barta, M.W. Clemens, A. Dogan, K. Fisher, A.M. Goodman, G. Goyal, J. Guitart, A. Halwani, B.M. Haverkos, R.T. Hoppe, E. Jacobsen, D. Jagadeesh, M.A. Lunning, A. Mehta, E.A. Olsen, B. Pro, S.A. Rajguru, S. Shanbhag, A. Shaver, A. Shustov, L. Sokol, P. Torka, C. Torres-Cabala, R. Wilcox, B.M. William, J. Zain, M.A. Dwyer, H. Sundar, and Y.H. Kim, NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. J Natl Compr Canc Netw, 2020. 18(5): p. 522-536.
- Jothishankar, B., C. Di Raimondo, L. Mueller, J. Zain, V. Parekh, and F. Abdulla, Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient. Pediatr Dermatol, 2020.
- Di Raimondo, C., V. Parekh, J.Y. Song, S.T. Rosen, C. Querfeld, J. Zain, X.U. Martinez, and F.R. Abdulla, Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review. Curr Hematol Malig Rep, 2020.
- Armenian, S.H., A. Iukuridze, J.B. Teh, K. Mascarenhas, A. Herrera, J.S. McCune, J.M. Zain, S. Mostoufi-Moab, S. McCormack, T.P. Slavin, J.M. Scott, L.W. Jones, C.L. Sun, S.J. Forman, F.L. Wong, and R. Nakamura, Abnormal body composition is a predictor of adverse outcomes after autologous hematopoietic cell transplantation. J Cachexia Sarcopenia Muscle, 2020.
- Armand, P., N. Murawski, D. Molin, J. Zain, B. Eichhorst, Z. Gulbas, E.A. Hawkes, J.M. Pagel, T. Phillips, V. Ribrag, J. Svoboda, A. Stathis, A. Chatterjee, R. Orlowski, P. Marinello, and B. Christian, Pembrolizumab in relapsed or refractory Richter syndrome. Br J Haematol, 2020.
- Zain, J.M., Aggressive T-cell lymphomas: 2019 updates on diagnosis, risk stratification, and management. Am J Hematol, 2019. 94(8): p. 929-946.
- Zain, J., Transplantation. Cancer Treat Res, 2019. 176: p. 269-287.